Enliven Therapeutics Inc. (Nasdaq: ELVN) reported this week that as of the end of 2025, the clinical-stage precision oncology company has $462.6 million in cash and equivalents, enough runway to fund ...
Q4 2026 Earnings Call March 4, 2026 5:00 PM ESTCompany ParticipantsGunnar Hansen - Director of Investor RelationsPeter Gassner ...
Chevrolet-powered cars have visited INDYCAR victory lane at Phoenix Raceway ten times, but the sacred place in Chevrolet ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results